Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Issuance of Common Stock

Amneal Pharmaceuticals Inc Issuance of Common Stock Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Issuance of Common Stock from 2017 to 2018.
  • Amneal Pharmaceuticals Inc Issuance of Common Stock for the quarter ending December 12, 2018 was $1m a -216.22% decrease of -1m year over year
  • Amneal Pharmaceuticals Inc Issuance of Common Stock for the last 12 months ending December 12, 2018 was $32m a 99.87% increase of 31m year over year
  • Amneal Pharmaceuticals Inc Annual Issuance of Common Stock for 2018 was $32m a 99.87% increase of 31m from 2017
  • Amneal Pharmaceuticals Inc Annual Issuance of Common Stock for 2017 was $0m
Other Cash Flow Metrics:
  • Amneal Pharmaceuticals Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $260m a 89.59% increase of 233m year over year
  • Amneal Pharmaceuticals Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $215m a 94.17% increase of 202m year over year
  • Amneal Pharmaceuticals Inc Total Revenue for the quarter ending December 12, 2018 was $498m a 44.69% increase of 222m year over year
View Chart On Koyfin

Quarterly AMRX Issuance of Common Stock Data

12/2018$1m
09/2018$1m
06/2018$30m
09/2017$2m
03/2017$0m

Annual AMRX Issuance of Common Stock Data

2018$32m
2017$0m